(+)-JQ 1
CAS: 1268524-70-4
Ref. 3D-FC43273
2mg | 136.00 € | ||
5mg | 172.00 € | ||
10mg | 271.00 € | ||
50mg | 754.00 € | ||
250mg | 1,133.00 € |
Product Information
- [(S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulen-6-yl]-acetic acid tert-butyl ester(S)-(
- (+)-Jq1
- (S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
- (S)-Jq1
- 1,1-Dimethylethyl (6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetate
- 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, 1,1-dimethylethyl ester, (6S)-
- BET domain inhibitor JQ1
- Bromodomain and extra-terminal domain inhibitor JQ1
- JQ1 (BET inhibitor)
- JQ1 (pharmaceutical)
- See more synonyms
- Jq-1
- tert-Butyl (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
Potent BET inhibitor with high specificity for acetyl-lysine recognition motifs found in the BET family (Brd2, Brd3, Brd4, Brdt). Engages with bromodomain pocket and competes with acetylated peptide binding, causing displacement of BET proteins from chromatin and disrupting transcription. Has been used in clinical trials as chemotherapy and male contraceptive.
Chemical properties
Technical inquiry about: 3D-FC43273 (+)-JQ 1
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.